$KOAN
Resonate Blends Inc Stock $koan

$koan Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224020796 Filed on May 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$95.05K	$0.00	$10.11K
YoY Change	840.44%	-100.0%	-63.45%
Cost Of Revenue	$31.20K	$100.9K	$8.572K
YoY Change	264.02%	1150.06%	-33.34%
Gross Profit	$63.85K	-$100.9K	$1.535K
YoY Change	4059.35%	-19880.39%	-89.62%
Gross Profit Margin	67.17%		15.19%
Selling, General & Admin	$480.7K	$105.9K	$98.42K
YoY Change	388.39%	-55.85%	-84.92%
% of Gross Profit	752.86%		6411.73%
Research & Development	$58.36K
YoY Change
% of Gross Profit	91.41%
Depreciation & Amortization	$1.890K	$2.270K	$3.000K
YoY Change	-37.0%	84.55%
% of Gross Profit	2.96%		195.44%
Operating Expenses	$480.7K	$105.9K	$98.42K
YoY Change	388.39%	-56.07%	-84.99%
Operating Profit	-$416.8K	-$206.8K	-$96.89K
YoY Change	330.23%	-14.05%	-84.88%
Interest Expense	-$305.6K	-$314.6K	-$186.4K
YoY Change	63.97%	449.92%	-116.28%
% of Operating Profit
Other Income/Expense, Net	-$3.272M	$116.9K	-$284.1K
YoY Change	1051.72%	1053.8%
Pretax Income	-$3.688M	-$404.6K	-$381.0K
YoY Change	868.23%	266.94%	-177.74%
Income Tax
% Of Pretax Income
Net Earnings	-$3.688M	-$404.6K	-$381.0K
YoY Change	868.22%	266.94%	-177.74%
Net Earnings / Revenue	-3880.56%		-3769.19%
Basic Earnings Per Share	-$0.04		-$0.01
Diluted Earnings Per Share	-$0.04	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	89.98M shares	86.62M shares	75.44M shares
Diluted Shares Outstanding	89.98M shares		75.44M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.19K	$6.940K	$1.040K
YoY Change	4437.5%	-89.23%	-99.44%
Cash & Equivalents	$47.19K	$6.938K	$1.042K
Short-Term Investments
Other Short-Term Assets	$970.0K	$970.0K
YoY Change
Inventory			$115.1K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.017M	$976.9K	$236.1K
YoY Change	330.81%	160.58%	-50.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.00K	$15.30K	$21.11K
YoY Change	136.9%	-36.54%	-25.5%
Goodwill
YoY Change
Intangibles	$4.804M	$0.00
YoY Change
Long-Term Investments	$1.880K	$100.00	$100.00
YoY Change	1780.0%	0.0%	0.0%
Other Assets	$42.50K
YoY Change
Total Long-Term Assets	$4.918M	$15.40K	$21.21K
YoY Change	23090.26%	-36.39%	-25.41%
TOTAL ASSETS
Total Short-Term Assets	$1.017M	$976.9K	$236.1K
Total Long-Term Assets	$4.918M	$15.40K	$21.21K
Total Assets	$5.935M	$992.3K	$257.3K
YoY Change	2206.44%	148.63%	-49.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$912.9K	$445.2K	$236.9K
YoY Change	285.37%	39.3%	-5.32%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$4.250M	$2.446M	$1.508M
YoY Change	181.9%	147.34%	-36.25%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.001M	$3.128M	$2.026M
YoY Change	196.18%	102.34%	-46.46%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.001M	$3.128M	$2.026M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.001M	$3.128M	$2.026M
YoY Change	196.18%	102.34%	-46.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.42M	-$26.74M	-$25.70M
YoY Change	18.38%	5.59%
Common Stock	$9.618K	$8.662K	$7.544K
YoY Change	27.49%	14.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$66.07K	-$2.136M	-$1.769M
YoY Change
Total Liabilities & Shareholders Equity	$5.935M	$992.3K	$257.3K
YoY Change	2206.44%	148.63%	-49.15%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.688M	-$404.6K	-$381.0K
YoY Change	868.22%	266.94%	-177.74%
Depreciation, Depletion And Amortization	$1.890K	$2.270K	$3.000K
YoY Change	-37.0%	84.55%
Cash From Operating Activities	-$199.2K	-$78.65K	$145.3K
YoY Change	-237.16%	-262.57%	-130.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$85.00K	$0.00
YoY Change
Cash From Investing Activities		-$85.00K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$239.5K	170.0K	-$208.6K
YoY Change	-214.79%	-165.69%	-132.1%
NET CHANGE
Cash From Operating Activities	-$199.2K	-78.65K	$145.3K
Cash From Investing Activities		-85.00K	0.000
Cash From Financing Activities	$239.5K	170.0K	-$208.6K
Net Change In Cash	$40.26K	6.350K	-$63.38K
YoY Change	-163.52%	-103.02%
FREE CASH FLOW
Cash From Operating Activities	-$199.2K	-$78.65K	$145.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	58-1588291
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Marine Plaza
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 305A
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	North Bergen
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	04047
CY2024Q1	dei	City Area Code CityAreaCode	203
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	253-9191
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	480674	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-416828	usd
CY2024Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	165514	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-140043	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89983758	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89983758	shares
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000897078
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent		usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	KOAN	Preferred Stock Issuable PreferredStockIssuable		usd
CY2023Q4	KOAN	Common Stock Issuable CommonStockIssuable		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
CY2023Q1	KOAN	Loss On Acquiition LossOnAcquiition		usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
CY2023Q1	KOAN	Gain Loss On Acquiition GainLossOnAcquiition		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	KOAN	Share Professional Fees Compensation ShareProfessionalFeesCompensation		usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2024Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt		usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2024Q1	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue		usd
CY2024Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross		usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-21202
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Resonate Blends, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	96179058	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6938	usd
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	970000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1017194	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	976938	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15303	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4803841	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1880	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	100	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42500	usd
CY2024Q1	us-gaap	Assets Assets	5934920	usd
CY2023Q4	us-gaap	Assets Assets	992341	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	912895	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	445219	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1535037	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1845734	usd
CY2024Q1	us-gaap	Senior Notes Current SeniorNotesCurrent	845443	usd
CY2023Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	600000	usd
CY2024Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1869800	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	166861	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6000985	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3127913	usd
CY2024Q1	us-gaap	Liabilities Liabilities	6000985	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3127913	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	96179058	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96179058	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86623596	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86623596	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	9618	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8662	usd
CY2024Q1	KOAN	Preferred Stock Issuable PreferredStockIssuable	4722776	usd
CY2024Q1	KOAN	Common Stock Issuable CommonStockIssuable	421312	usd
CY2024Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	261059	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	261059	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25465961	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24853028	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30424873	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26736403	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-66065	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2135572	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5934920	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	992341	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	95050	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10107	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	31204	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	8572	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	63846	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1535	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	18364	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	13284	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	342070	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	67172	usd
CY2024Q1	KOAN	Legal And Professional Fees LegalAndProfessionalFees	107740	usd
CY2023Q1	KOAN	Legal And Professional Fees LegalAndProfessionalFees	12965	usd
CY2024Q1	us-gaap	Officers Compensation OfficersCompensation	12500	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	5000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	98421	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-96886	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	46403	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-139951	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	10246	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	97712	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-32455	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	15000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	69243	usd
CY2024Q1	KOAN	Loss On Acquiition LossOnAcquiition	3007627	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3271642	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-284066	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3688470	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-380952	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75437604	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75437604	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1146730	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-247142	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-380952	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1768824	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2135572	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2135572	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	306985	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	421312	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	306904	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4722776	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3688470	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-66065	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-66065	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3688470	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-380952	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-140043	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-139951	usd
CY2024Q1	KOAN	Non Cash Interest Expense NonCashInterestExpense	10246	usd
CY2023Q1	KOAN	Non Cash Interest Expense NonCashInterestExpense	97712	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	69243	usd
CY2024Q1	KOAN	Gain Loss On Acquiition GainLossOnAcquiition	-2806683	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-32455	usd
CY2024Q1	KOAN	Share Professional Fees Compensation ShareProfessionalFeesCompensation	306985	usd
CY2024Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1890	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3004	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-45420	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-30000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	279672	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210134	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-19505	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-199244	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	145269	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	239500	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	95846	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	118800	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	239500	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-208646	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40256	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63377	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6938	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	64419	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47194	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1042	usd
CY2013Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	The Company also voted to approve a 1 for 5 reverse split of its outstanding common stock.
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30424873	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zUUe2MCmRrej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z9uCTpBSuP76">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	166861	usd
CY2024Q1	KOAN	Property And Equipment Excess Capitalized Cost PropertyAndEquipmentExcessCapitalizedCost	1000	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1000	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1537500	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1852800	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2463	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6766	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1535037	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1845734	usd

Files In Submission

Name	View Source	Status
0001493152-24-020796-index-headers.html	Edgar Link	pending
0001493152-24-020796-index.html	Edgar Link	pending
0001493152-24-020796.txt	Edgar Link	pending
0001493152-24-020796-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-1_004.jpg	Edgar Link	pending
ex10-1_005.jpg	Edgar Link	pending
ex10-1_006.jpg	Edgar Link	pending
ex10-1_007.jpg	Edgar Link	pending
ex10-1_008.jpg	Edgar Link	pending
ex10-1_009.jpg	Edgar Link	pending
ex10-1_010.jpg	Edgar Link	pending
ex10-1_011.jpg	Edgar Link	pending
ex10-1_012.jpg	Edgar Link	pending
ex10-1_013.jpg	Edgar Link	pending
ex10-1_014.jpg	Edgar Link	pending
ex10-1_015.jpg	Edgar Link	pending
ex10-1_016.jpg	Edgar Link	pending
ex10-1_017.jpg	Edgar Link	pending
ex10-1_018.jpg	Edgar Link	pending
ex10-1_019.jpg	Edgar Link	pending
ex10-1_020.jpg	Edgar Link	pending
ex10-1_021.jpg	Edgar Link	pending
ex10-1_022.jpg	Edgar Link	pending
ex10-1_023.jpg	Edgar Link	pending
ex10-1_024.jpg	Edgar Link	pending
ex10-1_025.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
ex10-2_002.jpg	Edgar Link	pending
ex10-2_003.jpg	Edgar Link	pending
ex10-2_004.jpg	Edgar Link	pending
ex10-2_005.jpg	Edgar Link	pending
ex10-2_006.jpg	Edgar Link	pending
ex10-2_007.jpg	Edgar Link	pending
ex10-2_008.jpg	Edgar Link	pending
ex10-2_009.jpg	Edgar Link	pending
ex10-2_010.jpg	Edgar Link	pending
ex10-2_011.jpg	Edgar Link	pending
ex10-2_012.jpg	Edgar Link	pending
ex10-2_013.jpg	Edgar Link	pending
ex10-2_014.jpg	Edgar Link	pending
ex10-2_015.jpg	Edgar Link	pending
ex10-2_016.jpg	Edgar Link	pending
ex10-2_017.jpg	Edgar Link	pending
ex10-2_018.jpg	Edgar Link	pending
ex10-2_019.jpg	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex4-1_001.jpg	Edgar Link	pending
ex4-1_002.jpg	Edgar Link	pending
ex4-1_003.jpg	Edgar Link	pending
ex4-1_004.jpg	Edgar Link	pending
ex4-1_005.jpg	Edgar Link	pending
ex4-1_006.jpg	Edgar Link	pending
ex4-1_007.jpg	Edgar Link	pending
ex4-1_008.jpg	Edgar Link	pending
ex4-1_009.jpg	Edgar Link	pending
ex4-1_010.jpg	Edgar Link	pending
ex4-1_011.jpg	Edgar Link	pending
ex4-1_012.jpg	Edgar Link	pending
ex4-1_013.jpg	Edgar Link	pending
ex4-1_014.jpg	Edgar Link	pending
ex4-1_015.jpg	Edgar Link	pending
ex4-1_016.jpg	Edgar Link	pending
ex4-1_017.jpg	Edgar Link	pending
ex4-1_018.jpg	Edgar Link	pending
ex4-1_019.jpg	Edgar Link	pending
ex4-1_020.jpg	Edgar Link	pending
ex4-1_021.jpg	Edgar Link	pending
ex4-1_022.jpg	Edgar Link	pending
ex4-1_023.jpg	Edgar Link	pending
ex4-1_024.jpg	Edgar Link	pending
ex4-2.htm	Edgar Link	pending
ex4-3.htm	Edgar Link	pending
ex4-3_001.jpg	Edgar Link	pending
ex4-3_002.jpg	Edgar Link	pending
ex4-3_003.jpg	Edgar Link	pending
ex4-3_004.jpg	Edgar Link	pending
ex4-3_005.jpg	Edgar Link	pending
ex4-3_006.jpg	Edgar Link	pending
ex4-3_007.jpg	Edgar Link	pending
ex4-3_008.jpg	Edgar Link	pending
ex4-3_009.jpg	Edgar Link	pending
ex4-3_010.jpg	Edgar Link	pending
ex4-3_011.jpg	Edgar Link	pending
ex4-3_012.jpg	Edgar Link	pending
ex4-3_013.jpg	Edgar Link	pending
ex4-3_014.jpg	Edgar Link	pending
ex4-3_015.jpg	Edgar Link	pending
ex4-3_016.jpg	Edgar Link	pending
ex4-3_017.jpg	Edgar Link	pending
ex4-3_018.jpg	Edgar Link	pending
ex4-3_019.jpg	Edgar Link	pending
ex4-3_020.jpg	Edgar Link	pending
ex4-3_021.jpg	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
koan-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
koan-20240331_cal.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
koan-20240331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
koan-20240331_def.xml	Edgar Link	unprocessable
koan-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KOAN
Resonate Blends Inc Stock $koan

2024 Q1 Form 10-Q Financial Statement

#000149315224020796 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOAN Resonate Blends Inc Stock $koan

2024 Q1 Form 10-Q Financial Statement

#000149315224020796 Filed on May 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOAN
Resonate Blends Inc Stock $koan